Global roadmap for hypertensive disorders of pregnancy from 2026 to 2035 and beyond

Overview

Hypertensive disorders of pregnancy, particularly pre-eclampsia and eclampsia, are major causes of maternal death and severe morbidity worldwide. They have lasting consequences for women’s cardiovascular health and contribute to stillbirth, preterm birth, newborn mortality and morbidity, and health-system costs. The burden is inequitable, with women and newborns in low- and middle-income countries (LMICs) disproportionately affected by gaps in access to quality care. Despite progress against other causes of maternal mortality, deaths from hypertensive disorders have declined too slowly over the past three decades, highlighting the need for coordinated action.

WHO, together with partners and stakeholders, developed the Global Roadmap for Hypertensive Disorders of Pregnancy 2026–2035 and beyond. It sets a shared vision and coordinated actions across five areas: research and innovation; norms and standards; access to health products; implementation; and advocacy and accountability. The Roadmap aims to accelerate progress towards ending preventable maternal and newborn mortality and morbidity and stillbirth associated with hypertensive disorders, while contributing to SDG targets 3.1 and 3.2. It aligns technical, policy and investment priorities, focusing on stronger health systems and equitable access to quality care, particularly in LMICs.